LipoMedix Announces Manufacturing Agreement with ForDoz for Promitil
LipoMedix, a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug…
Read More...
Read More...
